Concepedia

Rinke Bos

RB

13

Publications

2.3K

Citations

13

H-Index

2000

Active since

Affiliations

Leiden University Medical Center(Current)

Janssen (Netherlands)

Scripps Research Institute

Beth Israel Deaconess Medical Center

Rinke Bos is an author at Leiden University Medical Center specializing in immunology, medicine, and vaccine development.

Top concepts

Publications per year

2000–2023

13

Publications

13

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

Noe B. Mercado, Roland Zahn, Frank Wegmann et al. · Nature · 2020 · 889 citations · Full text

, , +3

CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes

Rinke Bos, Linda A. Sherman · Cancer Research · 2010 · 421 citations · Full text

, , +23

Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses

Rinke Bos, Lucy Rutten, Joan E. M. van der Lubbe et al. · npj Vaccines · 2020 · 367 citations · Full text

, , +18

Tumor-Specific CD4+ T Cells Render the Tumor Environment Permissive for Infiltration by Low-Avidity CD8+ T Cells

Soon Boon Justin Wong, Rinke Bos, Linda A. Sherman · The Journal of Immunology · 2008 · 137 citations · Full text

Functional differences between low- and high-affinity CD8<sup>+</sup>T cells in the tumor environment

Rinke Bos, Kristi Marquardt, Jocelyn Cheung et al. · OncoImmunology · 2012 · 76 citations · Full text

Rows per page

1–5 of 13